Centre for Medication Safety and Service Quality, Pharmacy Department, Imperial College Healthcare NHS Trust,Charing Cross Hospital, London W6 8RF, UK.
BMJ Qual Saf. 2013 Apr;22(4):278-89. doi: 10.1136/bmjqs-2012-001330. Epub 2013 Jan 15.
Medication administration errors (MAEs) are a problem, yet methodological variation between studies presents a potential barrier to understanding how best to increase safety. Using the UK as a case-study, we systematically summarised methodological variations in MAE studies, and their effects on reported MAE rates.
Nine healthcare databases were searched for quantitative observational MAE studies in UK hospitals. Methodological variations were analysed and meta-analysis of MAE rates performed using studies that used the same definitions. Odds ratios (OR) were calculated to compare MAE rates between intravenous (IV) and non-IV doses, and between paediatric and adult doses.
We identified 16 unique studies reporting three MAE definitions, 44 MAE subcategories and four different denominators. Overall adult MAE rates were 5.6% of a total of 21 533 non-IV opportunities for error (OE) (95% CI 4.6% to 6.7%) and 35% of a total of 154 IV OEs (95% CI 2% to 68%). MAEs were five times more likely in IV than non-IV doses (pooled OR 5.1; 95% CI 3.5 to 7.5). Including timing errors of ±30 min increased the MAE rate from 27% to 69% of 320 IV doses in one study. Five studies were unclear as to whether the denominator included dose omissions; omissions accounted for 0%-13% of IV doses and 1.8%-5.1% of non-IV doses.
Wide methodological variations exist even within one country, some with significant effects on reported MAE rates. We have made recommendations for future MAE studies; these may be applied both within and outside the UK.
用药错误(MAE)是一个问题,但研究之间方法学的差异可能会阻碍我们了解如何提高安全性。我们以英国为例,系统地总结了 MAE 研究中的方法学差异,并分析了它们对报告的 MAE 率的影响。
我们在九个医疗保健数据库中搜索了英国医院的定量观察性 MAE 研究。分析了方法学的变化,并对使用相同定义的研究进行了 MAE 率的荟萃分析。使用比值比(OR)比较了静脉(IV)和非-IV 剂量以及儿科和成人剂量之间的 MAE 率。
我们确定了 16 项独特的研究,报告了三种 MAE 定义、44 个 MAE 亚类和四个不同的分母。总体而言,成人 MAE 率为 21533 次非-IV 用药机会(OE)中的 5.6%(95%CI 4.6%至 6.7%)和 154 次 IV OE 中的 35%(95%CI 2%至 68%)。IV 剂量的 MAE 发生率是非-IV 剂量的五倍(合并 OR 5.1;95%CI 3.5 至 7.5)。在一项研究中,将 320 次 IV 剂量的时间错误±30 分钟包括在内,MAE 率从 27%增加到 69%。有五项研究不清楚分母是否包括剂量遗漏;遗漏占 IV 剂量的 0%-13%,占非-IV 剂量的 1.8%-5.1%。
即使在一个国家内,也存在广泛的方法学差异,其中一些对报告的 MAE 率有显著影响。我们为未来的 MAE 研究提出了建议;这些建议既可以在英国内部应用,也可以在英国外部应用。